Why RCEL? Avita Medical, Inc. Analysis, Price & AI Insights | Whystock
RCEL
$4.11-0.07 (-1.56%)
Market ClosedLast close May 8
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.